<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01029821</url>
  </required_header>
  <id_info>
    <org_study_id>Pugh-2</org_study_id>
    <nct_id>NCT01029821</nct_id>
  </id_info>
  <brief_title>Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis</brief_title>
  <official_title>Low-Molecular-Weight Heparin for DVT Prophylaxis After Open Reduction and Internal Fixation of Ankle Fractures: A Randomized, Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Tennessee</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. The use of LMWH following open reduction and internal fixation of ankle fractures will
           reduce the number of thrombi formed.

        2. The rates of clinically significant DVT will be equivalent between two groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Routine use of thromboprophylaxis may be over treatment and definitely increases healthcare
      costs. While prophylaxis may reduce the number of thrombi formed the exact number and
      clinical significance of these is unknown. This study seeks to answer the question of whether
      or not DVT prophylaxis with low-molecular-weight heparin (LMWH) following ORIF of ankle
      fractures is warranted.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>We will compare the rates of thrombi formation between the two groups. We will record any clinical significant thrombi or complications that arise from thrombi. We will record any complications related to administration of LMWH.</measure>
    <time_frame>first post-operative office visit (usually 10-14 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>We may find that there is in fact significant benefit to giving prophylaxis to this subset of patients in the form of decreased rates of throb\mbus formation and the complications related to thrombi. The risk/benefit ratio should be favorable.</measure>
    <time_frame>first post-operative office visit (10-14 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Deep Venous Thrombosis</condition>
  <arm_group>
    <arm_group_label>Low-Molecular-Weight Heparin for DVT</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Low-Molecular-Weight Heparin for DVT Prophylaxis after Open Reduction and Internal Fixation of ankle fractures</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-Molecular-Weight Heparin</intervention_name>
    <description>Isolated Ankle Fracture Single planned operation</description>
    <arm_group_label>Low-Molecular-Weight Heparin for DVT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years old

          -  Surgical ankle fracture able to be definitively treated with one operation

        Exclusion Criteria:

          -  Younger than 18 years of age

          -  Other significant injury

          -  Known hypercoagulable state

          -  History of bleeding disorder

          -  History of DVT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dale Ingram, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Tennessee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stan Ragon, M.D.</last_name>
    <phone>423-778-9202</phone>
    <email>stanragon@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elaine Pugh</last_name>
    <phone>423-778-5663</phone>
    <email>elaine.pugh@erlanger.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erlanger Medical Center</name>
      <address>
        <city>Chattanooga,</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dale Ingram, M.D.</last_name>
      <phone>423-266-3719</phone>
    </contact>
    <contact_backup>
      <last_name>Stan Ragon, M.D</last_name>
      <phone>423-778-9292</phone>
      <email>stanragon@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Dale Ingram, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2009</study_first_submitted>
  <study_first_submitted_qc>December 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2009</study_first_posted>
  <last_update_submitted>June 15, 2011</last_update_submitted>
  <last_update_submitted_qc>June 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Elaine Pugh</name_title>
    <organization>UTennessee</organization>
  </responsible_party>
  <keyword>Low-Molecular-Weight-Heparin</keyword>
  <keyword>Open Reduction and Internal Fixation</keyword>
  <keyword>Thromboprophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

